# Safety, Tolerability, Pharmacodynamics and Pharmacokinetics of Inhaled TPI 1100 in Healthy Volunteers

> **NCT00914433** · PHASE1 · WITHDRAWN · sponsor: **Syntara**

## Conditions studied

- Chronic Obstructive Pulmonary Disease

## Interventions

- **DRUG:** TPI 1100

## Key facts

- **NCT ID:** NCT00914433
- **Lead sponsor:** Syntara
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** WITHDRAWN
- **Start date:** 2009-04
- **Primary completion:** 2009-12
- **Final completion:** 2010-04
- **Target enrollment:** 0 (ACTUAL)
- **Why stopped:** Drug development suspended
- **Last updated:** 2012-12-03


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00914433

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00914433, "Safety, Tolerability, Pharmacodynamics and Pharmacokinetics of Inhaled TPI 1100 in Healthy Volunteers". Retrieved via AI Analytics 2026-06-03 from https://api.ai-analytics.org/clinical/NCT00914433. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*